Combination antiparkinson agents
- Level
- Class
- Parent
- 51140000
- Below
- 2
- Links · KBLI
- 8
Definition
UNSPSC 51143500This classification denotes combination drugs used in the treatment of a progressive, degenerative neurologic disease characterized by a tremor that is maximal at rest, retropulsion, rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression, a disorder called Parkinson Disease, hence the term ANTIPARKINSON AGENTS. Typical combination Antiparkinson agent constituents are carbidopa and levodopa.
Same parent
Under 51140000 · 30Activities that produce or sell this
KBLI · 8Inherited from family 51140000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.